Teva-Lenoltec No.4 · DIN 00621463 · 300 mg & 60 mg · tablet
General benefitMarketed · checked November 18, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
1 brand, same coverage
Teva-Lenoltec No.4 · DIN 00621463
Manufacturer: Teva Canada Limited; listing date 1996-10-01
Health Canada: Marketed since 2018-10-05 · brand TEVA-LENOLTEC NO. 4 · ATC N02AJ06 CODEINE AND PARACETAMOL · form Tablet · route Oral · ingredients ACETAMINOPHEN 300 MG, CODEINE PHOSPHATE 60 MG · company Rivex ophthalmics inc. · schedule Narcotics (cdsa i)
Teva-Lenoltec No.4: Formulary list price $0.19 per unit (the source does not state the unit; exact figure $0.1890). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 00621463)
Source record
DIN 00621463: Teva-Lenoltec No.4
Raw flags: sec3=Y
Item: 280808003; group id 397; item number 0951; lccId None; manufacturer id TEV
Source form: Tab; strength: 300mg & 60mg
Recorded listing: General benefit
Source prices (unrounded): $0.1890; ministry $0.1890
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=00621463
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=6824
Interchangeable products
Tylenol with Codeine No. 4 · DIN 02163918 · not recorded
Shortage status: not checked (no credentials)